Picture of Harvard Bioscience logo

HBIO — Harvard Bioscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Harvard Bioscience Reports Qtrly Revenue $27.0 mln

May 6 (Reuters) - Harvard Bioscience Inc  HBIO.O :
    * HARVARD BIOSCIENCE ANNOUNCES FIRST QUARTER 2021 FINANCIAL
RESULTS
    * HARVARD BIOSCIENCE INC QTRLY REVENUE $27.0 MILLION VERSUS
$23.8
MILLION
    * HARVARD BIOSCIENCE INC QTRLY LOSS PER COMMON SHARE $0.02
    * HARVARD BIOSCIENCE INC QTRLY ADJUSTED EARNINGS PER DILUTED
SHARE
$0.05
    * HARVARD BIOSCIENCE INC SEES REVENUE GROWTH OF 10% TO 14%
FOR
FISCAL 2021 COMPARED TO 2020

Source text for Eikon:  ID:nGNX5QW950 
Further company coverage:  HBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Harvard Bioscience

See all news